Effects of chloroquine on viral infections: an old drug against today's diseases?
- PMID: 14592603
- PMCID: PMC7128816
- DOI: 10.1016/s1473-3099(03)00806-5
Effects of chloroquine on viral infections: an old drug against today's diseases?
Abstract
Chloroquine is a 9-aminoquinoline known since 1934. Apart from its well-known antimalarial effects, the drug has interesting biochemical properties that might be applied against some viral infections. Chloroquine exerts direct antiviral effects, inhibiting pH-dependent steps of the replication of several viruses including members of the flaviviruses, retroviruses, and coronaviruses. Its best-studied effects are those against HIV replication, which are being tested in clinical trials. Moreover, chloroquine has immunomodulatory effects, suppressing the production/release of tumour necrosis factor alpha and interleukin 6, which mediate the inflammatory complications of several viral diseases. We review the available information on the effects of chloroquine on viral infections, raising the question of whether this old drug may experience a revival in the clinical management of viral diseases such as AIDS and severe acute respiratory syndrome, which afflict mankind in the era of globalisation.
Figures
Similar articles
-
New insights into the antiviral effects of chloroquine.Lancet Infect Dis. 2006 Feb;6(2):67-9. doi: 10.1016/S1473-3099(06)70361-9. Lancet Infect Dis. 2006. PMID: 16439323 Free PMC article. No abstract available.
-
Chloroquine: novel uses & manifestations.Indian J Med Res. 2008 Apr;127(4):305-16. Indian J Med Res. 2008. PMID: 18577785 Review.
-
Chloroquine enhances viral replication and murine disease.Am J Trop Med Hyg. 2000 Jan;62(1):1-3. doi: 10.4269/ajtmh.2000.62.1. Am J Trop Med Hyg. 2000. PMID: 10761717 No abstract available.
-
Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseases.Pharmacol Res Perspect. 2017 Jan 23;5(1):e00293. doi: 10.1002/prp2.293. eCollection 2017 Feb. Pharmacol Res Perspect. 2017. PMID: 28596841 Free PMC article. Review.
-
Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century.Int J Antimicrob Agents. 2007 Oct;30(4):297-308. doi: 10.1016/j.ijantimicag.2007.05.015. Epub 2007 Jul 16. Int J Antimicrob Agents. 2007. PMID: 17629679 Free PMC article. Review.
Cited by
-
Chloroquine: Rapidly withdrawing from first-line treatment of COVID-19.Heliyon. 2024 Aug 28;10(17):e37098. doi: 10.1016/j.heliyon.2024.e37098. eCollection 2024 Sep 15. Heliyon. 2024. PMID: 39281655 Free PMC article. Review.
-
An Update on the Study of the Molecular Mechanisms Involved in Autophagy during Bacterial Pathogenesis.Biomedicines. 2024 Aug 5;12(8):1757. doi: 10.3390/biomedicines12081757. Biomedicines. 2024. PMID: 39200221 Free PMC article. Review.
-
Artificial intelligence-aiding lab-on-a-chip workforce designed oral [3.1.0] bi and [4.2.0] tricyclic catalytic interceptors inhibiting multiple SARS-CoV-2 protomers assisted by double-shell deep learning.RSC Adv. 2024 Aug 27;14(37):26897-26910. doi: 10.1039/d4ra03965c. eCollection 2024 Aug 22. RSC Adv. 2024. PMID: 39193274 Free PMC article.
-
From Drug Discovery to Drug Approval: A Comprehensive Review of the Pharmacogenomics Status Quo with a Special Focus on Egypt.Pharmaceuticals (Basel). 2024 Jul 3;17(7):881. doi: 10.3390/ph17070881. Pharmaceuticals (Basel). 2024. PMID: 39065732 Free PMC article. Review.
-
Antimalarial Drugs at the Intersection of SARS-CoV-2 and Rheumatic Diseases: What Are the Potential Opportunities?Medicina (Kaunas). 2024 Jul 19;60(7):1171. doi: 10.3390/medicina60071171. Medicina (Kaunas). 2024. PMID: 39064600 Free PMC article. Review.
References
-
- Canadian rheumatology association Canadian Consensus Conference on hydroxychloroquine. J Rheumatol. 2000;27:2919–2921. - PubMed
-
- Savarino A, Gennero L, Sperber K, Boelaert JR. The anti-HIV-1 activity of chloroquine. J Clin Virol. 2001;20:131–135. - PubMed
-
- Boelaert JR, Piette J, Sperber K. The potential place of chloroquine in the treatment of HIV-1–infected patients. J Clin Virol. 2001;20:137–140. - PubMed
-
- Pescarmona GP, Morra E, Aldieri E, Ghigo D, Bosia A. Movements of vesicles in eukaryotic cells: role of intravesicle protons as a fuel and modulation of their concentration by drugs or metabolic changes. MRS Bull. 1998;489:212–217.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical